Drug recall D-0806-2026

Class II Ongoing reported Sep 9, 2026

Product

MYXREDLIN, Insulin Human in 0.9% Sodium Chloride Injection, 100 units/100 mL (1 unit/mL), Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0126-12.

Reason for recall

CGMP Deviations

Lots and codes

Lot # NC188630, NC188708, NC188791, NC188845, NC188876, NC188968, Exp Date: 12/31/2027; Lot # NC193719, NC193849, Exp Date: 04/30/2028; Lot # NC194051, NC194105, Exp Date: 05/31/2028; Lot # NC195171, Exp Date: 06/30/2028.

Recall details

Recalling firm
Baxter Healthcare Corporation, Deerfield, IL
Quantity
N/A
Distribution
US Nationwide; Puerto Rico; and Chile.
Type
Voluntary: Firm initiated
Recall initiated
August 6, 2026

Related products